Literature DB >> 25709552

Salivary gland scintigraphy in the evaluation of salivary gland dysfunction.

Sim Sai Tin1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2015        PMID: 25709552      PMCID: PMC4337015          DOI: 10.4103/1450-1147.150562

Source DB:  PubMed          Journal:  World J Nucl Med        ISSN: 1450-1147


× No keyword cloud information.
Dear Editor, The report on “Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction” is very interesting.[1] Senthilkumar and Sathasivasubramanian concluded that “there was a significant correlation between salivary flow rate and the scintigraphic uptake and excretory ratio.”[1] In fact, there is a previous similar report confirmed the good diagnostic protery of salivary gland scintigraphy.[2] Nevertheless, the false positive of the technique can be expected.[3] Salanci and Ergün noted that “bilateral radioactivity absence is observed usually due to drugs or radiopharmaceutical storage conditions.”[3] In case of existed salivary tumor, Yoshikai et al. noted that “adenoid cystic carcinomas and pleomorphic adenomas were the principal sources of false negative and false positive results, respectively.”[4]
  4 in total

1.  Patterns of salivary gland uptake in I-131 MIBG scintigraphy.

Authors:  B Volkan Salanci; E Lay Ergün
Journal:  Rev Esp Med Nucl       Date:  2006 May-Jun

2.  Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.

Authors:  Hasan Raza; Aakif U Khan; Abid Hameed; Ayub Khan
Journal:  Nucl Med Commun       Date:  2006-06       Impact factor: 1.690

3.  The limitations of gallium scintigraphy in the differentiation between benign and malignant salivary gland mass lesions.

Authors:  T Yoshikai; J Ishimaru; T Satoh; A Inokuchi; S Kudo
Journal:  Nucl Med Commun       Date:  2003-06       Impact factor: 1.690

4.  The Role of Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction in Uncontrolled Type II Diabetic Patients.

Authors:  B Senthilkumar; S Sathasivasubramanian
Journal:  World J Nucl Med       Date:  2013-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.